Supplemental material
Emerging Microbes & Infections
Volume 8, 2019 - Issue 1
Related Research Data
Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004
Source:
American Society for Microbiology
Emergence of AcrAB-mediated tigecycline resistance in a clinical isolate of Enterobacter cloacae during ciprofloxacin treatment
Source:
Elsevier BV
Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings
Source:
Taylor & Francis
Carbapenem-Resistant E. cloacae in Southwest China: Molecular Analysis of Resistance and Risk Factors for Infections Caused by NDM-1-Producers.
Source:
Frontiers Media SA
ANALYSIS OF RELATIVE GENE EXPRESSION DATA USING REAL-TIME QUANTITATIVE PCR AND THE 2(-DELTA DELTA C(T)) METHOD
Source:
Elsevier BV
Involvement of the AcrAB-TolC Efflux Pump in the Resistance, Fitness, and Virulence of Enterobacter cloacae
Source:
American Society for Microbiology
Tigecycline: what is it, and where should it be used?
Source:
Oxford University Press (OUP)
AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Source:
Oxford University Press (OUP)
Distinguishing between resistance, tolerance and persistence to antibiotic treatment.
Source:
Springer Science and Business Media LLC
Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae.
Source:
American Society for Microbiology
Cloning, Nucleotide Sequencing, and Analysis of the AcrAB-TolC Efflux Pump of Enterobacter cloacae and Determination of Its Involvement in Antibiotic Resistance in a Clinical Isolate
Source:
American Society for Microbiology
Local Repressor AcrR Regulates AcrAB Efflux Pump Required for Biofilm Formation and Virulence in Acinetobacter nosocomialis.
Source:
Frontiers Media S.A.
Linking provided by
